William Jones
Director/Board Member presso AKILI, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
William A.
Jones is currently the Director at LUNGevity Foundation, Director at Akili Interactive Labs, Inc., Independent Director at Akili, Inc., Director at Apogee Therapeutics, Inc., and Chief Commercial Officer at NewAmsterdam Pharma Co. NV.
Previously, he held positions such as Director of US Marketing at Bristol Myers Squibb Co., Vice President of Marketing & Business Development at NitroMed, Inc., Vice President & Head of Sales at AstraZeneca Pharmaceuticals LP, Vice President of Sales at Boehringer Ingelheim Pharmaceuticals, Inc., VP and Head of Sales & Commercial Operations at Takeda Pharmaceuticals U.S.A., Inc., and Chief Commercial Officer of Migraine & Common Disease at Biohaven Pharmaceutical Holding Co. Ltd.
He obtained a graduate degree from Texas A&M University, an undergraduate degree from the United States Air Force Academy, and an MBA from Stanford Graduate School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 13/07/2023 | 34 824 ( 0.08% ) | 2 M $ | 31/03/2024 |
Posizioni attive di William Jones
| Società | Posizione | Inizio |
|---|---|---|
| AKILI, INC. | Director/Board Member | 01/08/2022 |
| APOGEE THERAPEUTICS, INC. | Director/Board Member | 01/06/2023 |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Corporate Officer/Principal | 14/08/2023 |
LUNGevity Foundation
 LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris. | Director/Board Member | 26/05/2020 |
Akili Interactive Labs, Inc.
 Akili Interactive Labs, Inc. Information Technology ServicesTechnology Services Akili Interactive Labs, Inc. develops therapeutic mobile video games. It also develops platform technology that test and enhance the cognitive abilities through a video game. The company was founded by Adam Gazzaley, Daphne Zohar, Daphne Bavelier, and Eddie Martucci in 2011 and is headquartered in Boston, MA. | Director/Board Member | 18/08/2022 |
Precedenti posizioni note di William Jones
| Società | Posizione | Fine |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01/12/2022 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Sales & Marketing | 01/03/2019 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Sales & Marketing | 01/12/2016 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Sales & Marketing | 01/03/2013 |
| ░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di William Jones
| Texas A&M University | Graduate Degree |
| United States Air Force Academy | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AKILI, INC. | Health Technology |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| APOGEE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
LUNGevity Foundation
LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris. | Commercial Services |
Akili Interactive Labs, Inc.
Akili Interactive Labs, Inc. Information Technology ServicesTechnology Services Akili Interactive Labs, Inc. develops therapeutic mobile video games. It also develops platform technology that test and enhance the cognitive abilities through a video game. The company was founded by Adam Gazzaley, Daphne Zohar, Daphne Bavelier, and Eddie Martucci in 2011 and is headquartered in Boston, MA. | Technology Services |
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Borsa valori
- Insiders
- William Jones
